Erdemli, Mehmet ErmanAladag, M. ArifAltinoz, EyupDemirtas, SezinTurkoz, YusufYigitcan, BirgulBag, Harika Gozukara2019-07-042019-07-042018Erdemli, ME . Aladag, MA. Altinoz, E. Demirtas, S. Turkoz, Y. Yigitcan, B . Bag, HG. (2018). Acrylamide applied during pregnancy causes the neurotoxic effect by lowering bdnf levels in thefetal brain. Cilt:67. 37-43 ss.https://hdl.handle.net/11616/12340Objectives: The aim of this study is to elucidate the possible mechanism of neurotoxic effect of acrylamide (AA) applied during pregnancy on fetal brain development and to show the effect of N-acetylcysteine (NAC) on AA toxicity. Materials and methods: Four groups were formed with 9 pregnant rats each as control (C), acrylamide (AA), N-acetylcysteine (NAC), acrylamide plus N-acetylcysteine (AA plus NAC) groups. Caesarian section was implemented on the 20th day of pregnancy. Malondialdehyde (MDA), reduced glutathione (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), catalase (CAT) and Brain-derived neurotrophic factor (BDNF) levels were analyzed and histopathologic examinations were performed in brain tissues of the fetuses. Results: Our data indicated that AA caused necrotic death and hemorrhagic damages in fetal brain tissue with decreasing BNDF levels and increasing oxidative stress. N-acetylcysteine prevented the toxic effects of its on fetal brain (p < 0.05). Conclusion: Our study indicated that acrylamide has toxic effects in the fetal brain and N-acetylcysteine prevents its toxic effect.eninfo:eu-repo/semantics/openAccessN-acetylcysteıneneurotrophıc factordıetary-tınakeratfoodsupplementatıonneuroprotectıonneurogenesıshıppocampuscarcınogenArticle67374310.1016/j.ntt.2018.03.005